CLOSE

Genomic unit

Genomic Unit

Research overview. IEO is founding member of the two most important international scientific consortia dedicated to the use of Next Generation Sequencing technologies to investigate modifications of DNA and its associated proteins in normal and pathological tissues, Blueprint (www.blueprint-epigenome.eu) and IHEC (International Human Epigenome Consortium, ihec-epigenomes.org).

IEO considers research in genomics a strategic priority for the next decade. Since 2009 IEO has made significant investments in Genomics in collaboration with the Center for Genomic Sciences of the Italian Institute of Technology (IIT) hosted at our Campus. Currently, about ten research groups of the DEO-IEO and additional groups at the IIT are actively using Next Generation Sequencing technologies to investigate genome regulation and structure in the context of different aspects of tumor biology. This has led to the development of a highly integrated genomic research community including more than one hundred wet biologists, about 30 computational scientists, and a Technological Unit dedicated to genomic platforms and run in partnership by IEO and IIT.

The genomic research carried out at IEO has already led to a number of high-impact scientific publications and patents.

A SMALL GESTURE IS A GREAT HELP FOR US

PARTNERSHIP

Università degli Studi di Milano Ecancer Medical Science IFOM-IEO Campus

CREDITS

Ministero della Salute Joint Commission International Breastcertification bollinirosa

© 2013 Istituto Europeo di Oncologia - via Ripamonti 435 Milano - P.I. 08691440153

IRCCS - ISTITUTO DI RICOVERO E CURA A CARATTERE SCIENTIFICO

facebook IEO googleplus IEO twitter IEO pinterest IEO vimeo IEO